Krystalyn E. Hudson

2.5k total citations · 1 hit paper
54 papers, 1.4k citations indexed

About

Krystalyn E. Hudson is a scholar working on Hematology, Physiology and Immunology. According to data from OpenAlex, Krystalyn E. Hudson has authored 54 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 37 papers in Physiology and 20 papers in Immunology. Recurrent topics in Krystalyn E. Hudson's work include Blood groups and transfusion (36 papers), Erythrocyte Function and Pathophysiology (35 papers) and Immune Cell Function and Interaction (12 papers). Krystalyn E. Hudson is often cited by papers focused on Blood groups and transfusion (36 papers), Erythrocyte Function and Pathophysiology (35 papers) and Immune Cell Function and Interaction (12 papers). Krystalyn E. Hudson collaborates with scholars based in United States, Italy and France. Krystalyn E. Hudson's co-authors include James C. Zimring, Steven L. Spitalnik, Eldad A. Hod, Angelo D’Alessandro, Tiffany Thomas, Richard O. Francis, Kirk C. Hansen, Travis Nemkov, Davide Stefanoni and Jeanne E. Hendrickson and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Krystalyn E. Hudson

51 papers receiving 1.3k citations

Hit Papers

COVID-19 infection alters kynurenine and fatty acid metab... 2020 2026 2022 2024 2020 100 200 300

Peers

Krystalyn E. Hudson
Foo Cheung United States
Di Yan United States
Yaowu Zhu China
Young Ok Kim South Korea
T J Neale New Zealand
W. J. Jenkins United Kingdom
Krystalyn E. Hudson
Citations per year, relative to Krystalyn E. Hudson Krystalyn E. Hudson (= 1×) peers Fengchun Zhang

Countries citing papers authored by Krystalyn E. Hudson

Since Specialization
Citations

This map shows the geographic impact of Krystalyn E. Hudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krystalyn E. Hudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krystalyn E. Hudson more than expected).

Fields of papers citing papers by Krystalyn E. Hudson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krystalyn E. Hudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krystalyn E. Hudson. The network helps show where Krystalyn E. Hudson may publish in the future.

Co-authorship network of co-authors of Krystalyn E. Hudson

This figure shows the co-authorship network connecting the top 25 collaborators of Krystalyn E. Hudson. A scholar is included among the top collaborators of Krystalyn E. Hudson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krystalyn E. Hudson. Krystalyn E. Hudson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zotti, Flavia Dei & Krystalyn E. Hudson. (2025). Development and consequences of red blood cell autoantibodies: warm autoimmune hemolytic anemia. Current Opinion in Immunology. 95. 102604–102604.
2.
Zotti, Flavia Dei, et al.. (2024). Mitigation of checkpoint inhibitor–induced autoimmune hemolytic anemia through modulation of purinergic signaling. Blood. 144(15). 1581–1594. 5 indexed citations
3.
Anastasiadi, Alkmini T., Krystalyn E. Hudson, Anastasios G. Kriebardis, et al.. (2024). Exploring unconventional attributes of red blood cells and their potential applications in biomedicine. Protein & Cell. 15(5). 315–330. 12 indexed citations
4.
Jash, Arijita, James B. Collins, Ariel Hay, et al.. (2024). Complement C3 and marginal zone B cells promote IgG-mediated enhancement of RBC alloimmunization in mice. Journal of Clinical Investigation. 134(8). 5 indexed citations
5.
Jajosky, Ryan Philip, Kashyap Patel, Patricia E. Zerra, et al.. (2023). Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression. Blood. 142(12). 1082–1098. 17 indexed citations
6.
Thomas, Tiffany, Monika Dzieciątkowska, Flavia Dei Zotti, et al.. (2023). Reticulocytes in donor blood units enhance red blood cell alloimmunization. Haematologica. 108(10). 2639–2651. 15 indexed citations
7.
Jajosky, Ryan Philip, Seema R. Patel, Shang‐Chuen Wu, et al.. (2023). Prior Immunization to an Intracellular Antigen Enhances Subsequent Red Blood Cell Alloimmunization in Mice. Blood. 141(21). 2642–2653. 13 indexed citations
8.
Dillon, Stacey R., R. H. Davies, Jason D. Lickliter, et al.. (2023). S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES. HemaSphere. 7(S3). e3301055–e3301055. 1 indexed citations
9.
Arthur, Connie M., Seema R. Patel, Patricia E. Zerra, et al.. (2022). Clodronate inhibits alloimmunization against distinct red blood cell alloantigens in mice. Transfusion. 62(5). 948–953. 12 indexed citations
10.
Zotti, Flavia Dei, Manjula Santhanakrishnan, Jeanne E. Hendrickson, et al.. (2022). FcγRIV is required for IgG2c mediated enhancement of RBC alloimmunization. Frontiers in Immunology. 13. 972723–972723. 10 indexed citations
11.
Liu, Jingchun, David R. Gibb, Manjula Santhanakrishnan, et al.. (2020). Poly(I:C) causes failure of immunoprophylaxis to red blood cells expressing the KEL glycoprotein in mice. Blood. 135(22). 1983–1993. 5 indexed citations
12.
Howie, Heather L., Ariel Hay, Hayley R. Waterman, et al.. (2020). IgG Subclass Determines Suppression Versus Enhancement of Humoral Alloimmunity to Kell RBC Antigens in Mice. Frontiers in Immunology. 11. 1516–1516. 19 indexed citations
13.
Gruber, David, et al.. (2020). Tolerization of recent thymic emigrants is required to prevent RBC-specific autoimmunity. Journal of Autoimmunity. 114. 102489–102489. 7 indexed citations
14.
Bertolone, Lorenzo, Davide Stefanoni, Jin Hyen Baek, et al.. (2020). ZOOMICS: Comparative Metabolomics of Red Blood Cells From Old World Monkeys and Humans. Frontiers in Physiology. 11. 593841–593841. 19 indexed citations
15.
Richards, Amanda L., et al.. (2018). The Role of the Immunological Synapse in Differential Effects of APC Subsets in Alloimmunization to Fresh, Non-stored RBCs. Frontiers in Immunology. 9. 2200–2200. 9 indexed citations
16.
Hudson, Krystalyn E., et al.. (2017). Antibodies to Senescent Antigen and C3 Are Not Required for Normal Red Blood Cell Lifespan in a Murine Model. Frontiers in Immunology. 8. 1425–1425. 4 indexed citations
17.
Richards, Amanda L., Heather L. Howie, Linda M. Kapp, et al.. (2017). Innate B-1 B Cells Are Not Enriched in Red Blood Cell Autoimmune Mice: Importance of B Cell Receptor Transgenic Selection. Frontiers in Immunology. 8. 1366–1366. 5 indexed citations
18.
Richards, Amanda L., Linda M. Kapp, Xiaohong Wang, Heather L. Howie, & Krystalyn E. Hudson. (2016). Regulatory T Cells Are Dispensable for Tolerance to RBC Antigens. Frontiers in Immunology. 7. 348–348. 13 indexed citations
19.
Hudson, Krystalyn E., Jeanne E. Hendrickson, Chantel M. Cadwell, Neal N. Iwakoshi, & James C. Zimring. (2012). Partial tolerance of autoreactive B and T cells to erythrocyte-specific self-antigens in mice. Haematologica. 97(12). 1836–1844. 15 indexed citations
20.
Hendrickson, Jeanne E., Eldad A. Hod, Krystalyn E. Hudson, Steven L. Spitalnik, & James C. Zimring. (2011). Transfusion of fresh murine red blood cells reverses adverse effects of older stored red blood cells. Transfusion. 51(12). 2695–2702. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026